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Abstract
Background and methods: Data on patients with fever of unknown origin (FUO ) show that the problem of FU O  
differs, depending on place and time. To obtain a better insight into FU O  in the Netherlands, we performed a 
retrospective study in our University Hospital.
Results: We studied 53 patients fulfilling FU O  criteria. Infection was found in 11 patients (21%), neoplasms in 10 
cases (19%), non-infectious inflammatory diseases in 12 patients (23%). In 16 patients (30%) no diagnosis could be 
made. In 12 patients fever subsided. In 4 patients fever persisted with a median follow-up of 14.5 years. In all 5 
patients without directional clues no diagnosis could be made. In 21 patients (57%) the diagnosis was found by 
non-invasive methods, in 16 patients (43%) invasive methods were necessary. A  median of 54 investigations were 
done in all patients.
Conclusions: The spectrum of FU O  is changing. The proportion of patients in whom no diagnosis can be made is 
growing. The presence of directional clues seems to be an important issue, which other series often do not mention. 
Their importance should be studied in a larger, prospective study. The use of sophisticated diagnostic techniques 
seems to be extensive. Because very little is known about the diagnostic yield of many of those techniques, a 
prospective study on this aspect is needed.
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1. Introduction
Despite all advanced diagnostic techniques 
available nowadays, fever of unknown origin 
(FUO) remains a diagnostic challenge. Many se­
ries of patients with classical FUO, according to 
Petersdorf s criteria [1] (i.e. febrile illness of more
Corresponding author. Tel. (080) 614763; Fax (080) 
541734.
than 3 weeks duration, fever higher than 38.2° C 
on at least 3 occasions and uncertain diagnosis 
after 1 week of study in a hospital) have been 
published [1-10].
When studying these data it is obvious that the 
problem of FUO differs depending on place and 
time. The composition of the groups varies and 
several other factors (i.e. geographic area, changes 
in diagnostic procedures, changes in disease pat­
tern, hospital setting) can be held responsible for 
this.
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At the time of this study, few recent data were 
available from North-Western Europe. Only the 
study by Knockaert et al. [10] originates from this 
part of the world. In order to obtain a better 
insight into FUO in our area, we performed a 
retrospective study in our University hospital.
2. Materials and methods
Using the registration system for patients ad­
mitted to our department from August 1988 to 
January 1992, 111 charts of patients admitted
because of fever were reviewed. Of these only 27 
patients fulfilled the criteria of Petersdorf. The 
registration systems for diagnosis at discharge 
were also checked for patients with fever of un­
known origin. Of 132 patients only 2 had classical 
FUO. Other patients were retrieved by examining 
all charts of patients submitted to indium-ill- 
labeled polyclonal immunoglobulin G scintigra­
phy (5 patients) [11] or by checking temperature 
lists and microbiology consultation lists (19 pa­
tients). The risk of missing patients and selection 
is less due to the use of more searching tech­
niques.
Table 1
The diagnostic categories of 53 cases of FUO
Category No. of cases (% of total)
Infection 11 (21%)
Persistent yersiniosis 3
Spondylodiscitis (Streptococcus pyogenes serogroup B) 2
Tuberculous spondylodiscitis 1
Endocarditis (culture negative) 1








Acute myelogenous leukemia 2
Solid tumours
Renal cell carcinoma 1
Metastatic bronchial carcinoma in the ileum 1
Colonic carcinoma 1
Non-infectious inflammatory diseases 12(23%)
Non-classifiable inflammatory disease 3
Periarteritis nodosa 1
Systemic lupus erythematosus 1
Polymyalgia rheumatica 1
Adult Still’s disease 1
Inflammatory bowel disease 3
Sarcoidosis 1
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Final diagnoses reported in this study were 
made by the authors upon critical revision of the 
data and diagnosis mentioned in medical records.
For every patient we checked the presence and 
usefulness of directional clues (i.e. diagnostic ab­
normalities) which pointed to certain possible 
diagnoses and enabled the attending physician to 
order specific investigations. This clues varied 
from clues in the history (e.g., tropical trips) to 
abnormalities on physical examination (e.g., pleu­
ral effusion, hepatosplenomegaly or lym- 
phadenopathy). In patients without such clues, all 
diagnostic testing had to be performed in a blind 
fashion. Diagnostic procedures were studied and 
counted in each patient.
Recurrent fever in this study was defined as 
repeated bouts of fever with fever-free intervals 
of at least 2 weeks and apparent remission of the 
underlying disease.
Data were statistically analyzed and groups of 
patients compared with Fisher’s exact test. A 
p-value of < 0.05 was considered significant.
3. Results
A total of 53 patients was retrieved (25 men 
and 28 women; median age of 51 years, range, 
19-80 years). Eighteen patients had some form of 
recurrent fever. Nine patients per year were re­
trieved in 1988 and 1989; in 1990 and 1991, 17
Fig. 1. Distribution of duration of fever before hospitalisation 
in 53 patients with FUO. Duration of fever was calculated 
according to Petersdorf, using the start of febrile illness as the 
first day. With recurrent fever, the summation of febrile days 
is given.
and 18 were found, respectively. Twenty-eight 
patients (53%) had already been investigated by 
internists in other hospitals and came for a sec­
ond opinion. Seven patients (13%) were seen by 
us in consultation at other departments or al­
ready admitted because of non-febrile diseases.
The median duration of hospitalization was 23 
days (range 5 to 171 days), in 21 patients (40%) 
the duration of hospitalization exceeded 4 weeks. 
Five patients were admitted in other hospitals 
and seen at the outpatients’ department in our
Table 2
The diagnostic categories of IS patients with recurrent fever
Category' No. of fever periods in each patient No. of cases (% of total)
Infection 5 (28%)
Salmonella bacteraemia 9
Persistent yersiniosis (3 cases) 3, 4 and > 5
Chronic meningococcaemia 3
Neoplasm 0
Non-infectious inflammatory' diseases 4 (22%)
Non-classifiable inflammatory disease > 5




No diagnosis 7 (39%)
0-7  8-21 22 -35  3 6 -6 3  64-180 >180
duration of fever (days)
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hospital. Fig. 1 presents the duration of fever 
before admission to the hospital (median dura­
tion, 40 days).
In our series, infection was the most common 
cause of FUO (21%). Neoplasms accounted for 
10 cases (19%). Non-infectious inflammatory dis­
eases were the cause of fever in 12 patients (23%) 
(Table 1). In 16 patients (30%) no diagnosis could 
be made. In 12 patients fever subsided sponta­
neously after a duration of median 115 days (range 
28 days-38 months). In 4 patients fever (periods) 
persisted and no diagnosis could be made until 
now (median duration 14.5 years; range 1.6-25.8 
years). These 4 patients all had some form of 
recurrent fever.
In 7 patients the diagnosis was made during 
follow-up after discharge, because of new emerg­
ing facts (endocarditis, lupus erythematosus, an- 
gio-immunoblastic lymphadenopathy with dyspro- 
teinaemia, leukaemic transformation after 
myelofibrosis, Hodgkin’s disease, ulcerative colitis 
and Crohn’s disease).
Some patients received non-steroidal anti-in­
flammatory drugs. This was not done on a proto-
Table 3
The diagnostic categories of 22 patients with FUO of more 
than 180 days before diagnosis or recovery









Acute myelogenous leukaemia 1
Angio-immunoblastic lymphadenopathy 1
Non-infectious inflammatory diseases 8 (36%)
Non-classifiable inflammatory disease 2
Polymyalgia rheumatica 1
Systemic lupus erythematosus 1
Inflammatory bowel disease 3





Laboratory procedures used to establish a final diagnosis in 37 
FUO patients
Diagnostic method No. of cases (%)
Non-inuasive
Serology or bacteriology 11 (30)
Radiology 2(5)
Endoscopy 3(8)




colary basis and the effect could not always be 
evaluated.
In 5 patients, no directional clues were present 
and all diagnostic testing was performed in a 
blind fashion. In no patient in this group was a 
diagnosis made. In contrast, no diagnosis was 
made in 11 (23%) of 48 patients with directional 
clues ( p  = 0.0015). In 23 patients (48%) with a 
clue, the clue was misleading.
In 18 patients, some form of recurrent fever 
was present (Table 2). No diagnosis could be 
made in 7 (39%) of these 18 patients. This finding 
is not significantly different ( p  = 0.16) from the 
group of 35 patients with continuous fever, in 
which no diagnosis could be made in 9 cases 
(26%).
In 22 patients, duration of fever before diagno­
sis or recovery was longer than a half year (Table 
3). In 9 patients no diagnosis could be made 
(41%). This is not significantly different from the 
number of diagnoses made in patients with shorter 
duration of fever (p  = 0.13).
Diagnostic procedures
Of the 37 patients in whom a final diagnosis 
was established, the diagnosis was found by non- 
invasive methods in 21 (57%). The diagnosis was 
made by invasive methods in 16 patients (43%), 
mostly biopsies (Table 4).
A median of 54 investigations (range 23-83) 
was performed in all patients and there was no 
significant difference between patients with or 
without directional clues. There was also no sig­
nificant difference in patients with true or false 
clues. Table 5 shows the frequency of specific 
investigations performed.
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4. Discussion
Most striking in our series is the large propor­
tion of patients in whom no diagnosis could be 
made. This is in agreement with the findings of 
Knockaert et al. [10]. There are several possible 
explanations. Firstly, a high percentage (53%) of 
cases in our series had undergone investigations 
elsewhere, before referral to our hospital. In most 
other, older series exact data on the referral
pattern are lacking [1-5,7-9]. It is likely that by 
selection more patients are encountered in refer­
ral centres, which are difficult to diagnose and 
have a lower chance of reaching a final diagnosis. 
Secondly, with the advent of advanced diagnostic 
techniques, certain disease entities that used to 
be found in patients with FUO (e.g, hepatobiliary 
diseases, abdominal abscesses, liver and kidney 
tumours, lymphoma and mediastinal or hilar ab­
normalities) can now be established more easily
Table 5
Frequency of investigations performed in 53 patients with FUO
Frequency (%) Investigations
100 ESR, haemoglobin, platelets, total leukcocytes,
creatinine, chest radiograph
> 90 Liver function tests, total serum protein, albumin, urine protein and urinalysis,
differentiation of leukocytes, blood cultures
> 80 Electrolytes, serum protein fractions, urine culture,
antinuclear antibodies
> 70 Faecal cultures, abdominal ultrasonography
> 60 Immunoelectrophoresis, faecal occult blood, rheumatoid factor,
serology on cytomegalovirus
> 50 Creatine kinase, angiotensin-converting enzyme, complement C3 and C4, PPD,
antibodies to hepatitis B, abdominal CT.
> 40 Anti-dsDNA, ENA, ACPA, serology for syphilis, respiratory virus infections,
hepatitis A, Epstein-Barr virus, brucellosis,toxoplasmosis, m In-IgG scintigraphy
> 30 Iron, iron-binding capacity, thyroid function, haemostasis tests,
sputum culture, ASO, serology for Chlamydia infection, yersiniosis and borreliosis, 
bone marrow aspiration, liver biopsy, transthoracal echocardiography, X-ray of sinuses
> 25 Haptoglobin, specific cultures, bone marrow cultures,
serology for Q-fever and human immunodeficiency virus, CRP. skin biopsy.
X-ray of spine, 111 In-WBC scintigraphy
> 20 Amylase, serology for Mycoplasma, X-ray colon,
thoracic CT, coloscopy
> 15 Vitamin B 12, folate, ferritin, culture of throat, culture of bronchoalveolar lavage,
CSF culture, Widal test, cryoglobulin, blood smear examination for malaria, 
serology for hepatitis C, X-ray ileum, ventilation/perfusion scintigraphy, cerebral CT, 
intravenous pyelography, lung biopsy, bone biopsy, skin-muscle biopsy, bronchoscopy
> 10 Urate, cholesterol, immunoglobulin D, prostatic phosphate,
antimitochondrial antibody, lymph node biopsy, specific biopsies, temporal biopsy, 
gastroscopy, pelvic ultrosonography, dental radiography 
< 10 «-Fetoprotein, IgE, vitamin E, porphyrins, CEA, cultures of skin, liver,
cervix, pleural fluid, and intravenous lines, serology for leptospirosis, 
gonorrhoea, Campylobacter infection, amoebiasis, legionellosis, schistosomiasis, 
cat-scratch disease, histoplasmosis, Bilharzia infections, trypanosomiasis, 
rickettsiosis, lysozyme, anti-smooth muscle antibody, renal biopsy, biopsy of pleura, 
rectum, ileum, and colon, X-ray of stomach, ERCP, laparotomy, laparoscopy, thoracoscopy, 
mediastinoscopy, specific CT, specific M RI, EMG, oesophageal echocardiography
ACPA = anticytoplasmic antigen; ASO = anti-streptolysin O-test; CEA = carcino-embryonic antigen; CRP = C-reactive 
protein; CSF = cerebrospinal fluid; CT = computerized tomography; EM G = electromyography; ENA = extractable nuclear 
antigen; ERCP = endoscopic retrograde cholangio-pancreaticography; ESR = erythrocyte sedimentation rate; m In-IgG = 
indium-111-labeled immunoglobulin G; 111 In-WBC = indium-111-labeled white blood cells; M R I = magnetic resonance imaging; 
PPD = purified protein derivative (tuberculin skin test).
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within 1 week of admission or even at the outpa­
tient department. This leaves us with a group of 
patients, fulfilling classical criteria, in whom a 
diagnosis is much more difficult to make.
As in nearly all series of FUO, infection was a 
frequently established diagnosis, but, as expected, 
our study revealed no abscesses or hepatobiliary 
diseases. Tuberculosis and endocarditis were rare 
causes of FUO in accordance with the series of 
Larson [3] and Knockaert [10]. More remarkable 
is the diagnosis persistent Yersinia enterocolitica 
infection, which was made in 3 patients. This was 
made possible by the use of sensitive and specific 
immunoblotting techniques. The most often used 
Yersinia agglutination reaction is often negative in 
chronic Yersinia infection [12,13], and thus this 
diagnosis may have been missed in other series.
Compared with other series from university 
hospitals [1-5], we found a low percentage of 
tumours as the cause of fever. In their study, 
Knockaert et al. [10] also found a low percentage 
(7%) of neoplasms. As expected, tumours of the 
alimentary tract (colonic cancer) and some 
haematological malignancies (Hodgkin's disease 
and angio-immunoblastic lymphadenopathy) re­
main difficult to diagnose and therefore remain a 
cause of FUO, because of lack of localising symp­
toms or difficulty in obtaining appropriate biop­
sies.
Most series of FUO distinguish a category of 
diseases called “collagen disorders”, which also 
includes vasculitis and so called autoimmune dis­
eases. Since collagen is involved in only a few of 
these disorders, and an autoimmune nature is 
often difficult to prove, we would prefer a cate­
gory called non-infections inflammatory diseases. 
This category would also include inflammatory 
bowel disease and sarcoidosis, diseases usually 
listed under “miscellaneous disorders”. It should 
be noted that some of the diseases now catego­
rized as “ non-infectious inflammatory” may actu­
ally turn out to have an infectious aetiology (as 
was recently demonstrated definitively for Whip­
ple’s disease). Non-infectious inflammatory dis­
eases that are accompanied by fever are rather 
often classified rather as FUO. Fever may pre­
cede more typical manifestations or serological 
evidence by weeks or months. A number of these
diseases, such as adult Still's disease, polymyalgia 
rheumatica and mixed connective tissue disease, 
can only be diagnosed by exclusion and pro­
longed observation may be necessary. Some of 
these disorders have symptoms in common with 
paraneoplastic syndromes. In contrast to Knock­
aert et al. [10] who reported 8.5% of temporal 
arteritis, we did not encounter this diagnosis in 
our series; one of the patients with polymalgia 
rheumatica and one patient with a probable non- 
infectious inflammatory disease could have had 
temporal arteritis, but biopsies were not per­
formed in these 2 patients. Inflammatory bowel 
disease can present very atypically for many years, 
with few abdominal complaints and therefore re­
main important causes of FUO and recurrent 
fever (Table 2).
The presence or absence of directional clues 
which we consider an important issue, is not 
explicitly mentioned in most previous series [1- 
6,8,10]. Kazanjian [14] states that 9 of 86 patients 
with FUO (10%) had no directional clue, Wan- 
varie et al. [9] mention that 3 of 25 (12%) patients 
with FUO had no clues, and Deal [7] describes 
this in 11 of 34 cases (32%). In the absence of 
directional clues, we find that the likelihood of 
reaching a diagnosis is very low. Wanvarie et al. 
also noted this in their series. Their series and 
ours are small and retrospective, and because it is 
sometimes difficult to deduce in retrospective 
which clues were directional for the attending 
physician, this should be studied in a larger 
prospective study.
The chances of reaching a diagnosis in patients 
with continuous fever (74%) seems somewhat 
higher than in patients with some form of recur­
rent fever (61%), although the difference is not 
significant. Knockaert et al. also find that it is 
hard to reach a diagnosis in the latter group [15]. 
Neoplasms were not found to cause recurrent 
fever in our series and only in 4% of 45 cases of 
recurrent fever in Knockaert’s series [15]. Al­
though the data are limited and more informa­
tion on this subgroup is needed, it seems that this 
group of patients with FUO could be followed as 
outpatients, without aggressive or invasive diag­
nostic procedures, after having clinically observed 
one attack of fever.
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In 22 patients (42%) the duration of fever was 
longer than 180 days. In this group fewer infec­
tions were found (9%) and there were more pa­
tients with no diagnosis (41%). The difference in 
diagnostic categories between this group and the 
group of patients in whom duration of fever was 
less than 180 days was not significant. Barbado 
found in 110 patients with FUO 15 patients (14%) 
with prolonged FUO; in 4 of these patients (27%) 
no diagnosis could be made [16]. In another se­
ries of 133 patients with FUO, he could not make 
a diagnosis in 28% [2].
Because we wanted to get an insight into the 
diagnostic strategies, we studied the investiga­
tions performed in patients with FUO. Many 
investigations were apparently ordered in a blind 
manner, without specific directional clues point­
ing to the diagnosis sought. In contrast, some 
commonly performed investigations (e.g., blood 
cultures, serum protein fractions, antinuclear an­
tibodies were not done in some patients (Table 
5). Although very little is known at present about 
the diagnostic yield of microbiological, immuno- 
histological and imaging techniques in patients 
with FUO, the use of these investigations seems 
abundant. A thorough prospective investigation is 
needed to investigate the various diagnostic yields. 
An additional question is in which subgroups of 
patients with FUO certain investigations are use­
ful. Because of the diversity of patients with 
FUO, prospective studies are needed that either 
are large enough or focus on certain subgroups. 
Only with this information can justified algo­
rithms be made.
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